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Two distinct chitinases have been identified in mammals: a phagocyte-spe-
cific enzyme named chitotriosidase and an acidic mammalian chitinase (AMCase) expressed
in the lungs and gastrointestinal tract. Increased expression of both chitinases has been ob-
served in different pathological conditions: chitotriosidase in lysosomal lipid storage disor-
ders like Gaucher disease and AMCase in asthmatic lung disease. Recently, it was reported
that AMCase activity is involved in the pathogenesis of asthma in an induced mouse model.
Inhibition of chitinase activity was found to alleviate the inflammation-driven pathology.
We studied the tissue-specific expression of both chitinases in mice and compared it to the
situation in man. In both species AMCase is expressed in alveolar macrophages and in the
gastrointestinal tract. In mice, chitotriosidase is expressed only in the gastrointestinal tract,
the tongue, fore-stomach, and Paneth cells in the small intestine, whereas in man the en-
zyme is expressed exclusively by professional phagocytes. This species difference seems to
be mediated by distinct promoter usage. In conclusion, the pattern of expression of chitin-
ases in the lung differs between mouse and man. The implications for the development of
anti-asthma drugs with chitinases as targets are discussed.
 






, mammalian chitinases have attracted con-
siderable attention. Of particular interest is the claim
that activity of an endogenous lung chitinase plays a
key role in the pathogenesis of asthma in an induced
mouse model (Zhu et al. 2004). The existence of en-
dogenous mammalian chitinases has been relatively re-
cently documented. The finding of a profound chito-
triosidase activity in plasma of Gaucher patients formed
the basis for subsequent identification and character-
ization of a human phagocyte-specific chitinase named
chitotriosidase (Hollak et al. 1994; Boot et al. 1995;
Renkema et al. 1995,1998). Human tissue macrophages
are able to produce large amounts of chitotriosidase
upon appropriate stimulation, such as the massive lipid
accumulation that occurs in macrophages of Gaucher
patients. Macrophages secrete a 50-kDa active enzyme,
which consists of a catalytic domain and a C-terminal
chitin-binding domain separated by a hinge region
(Renkema et al. 1997; Tjoelker et al. 2000). Chitotri-
osidase is not expressed in other cell types with the ex-
ception of progenitors of neutrophilic granulocytes.
These cells synthesize 50-kDa chitotriosidase that is
stored in their specific granules (Boot et al. 1995; Bous-
sac and Garin 2000).
The physiological function of chitotriosidase is not
completely resolved. Its phagocyte-specific expression
suggests a role in innate immunity. Highly homolo-
gous plant chitinases are prominent “pathogenesis-
related proteins” that are induced following attack by
pathogens and take part in the defense against chitin-
containing fungi (Schlumbaum et al. 1986; Sahai and
Manocha 1993). A similar role for chitotriosidase in
the human innate immune system is indicated by our
observation that recombinant chitotriosidase is fungi-
static in mice models of systemic fungal infections
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1 in 20 in-
dividuals is completely deficient in chitotriosidase ac-
tivity due to a 24-bp duplication in the gene that occurs
panethnically (Hollak et al. 1994; Boot et al. 1998).
This high prevalence of deficiency suggests that hu-
man chitotriosidase either no longer fulfills an impor-
tant function under normal conditions or that other
mechanisms may compensate for the lack of a func-
tional chitinase (Boot et al. 1998). The occurrence of
deficiency in chitotriosidase is associated with suscep-





ial parasite whose microfilarial sheath contains chitin
(Choi et al. 2001). In search of compensatory chitin-
ases in mammals we identified and characterized a
second mammalian chitinase named acidic mamma-
lian chitinase (AMCase) (Boot et al. 2001). This 50-kDa
enzyme is structurally highly related to chitotriosidase.
AMCase occurs in the gastrointestinal tract and
lungs of rodents and man. Suzuki et al. (2002) also
detected AMCase mRNA in exocrine cells of the se-
rous type of mice. Unlike human chitotriosidase, AMC-
ase has an acidic pH optimum and is very acid stable
(Boot et al. 2001). The enzyme appears to be adapted
to function in the extreme stomach environment, where
it may fulfill a role in defense and/or digestion of
chitin-containing organisms.
In the lung of mice, but not of man, AMCase is the
sole detectable endogenous chitinase. In a number of
recent reports the mRNA expression of AMCase in
the lung of mice was shown to be highly regulated
(Sandler et al. 2003; Xu et al. 2003; Zhu et al. 2004;




 eggs was found to cause massive
expression of AMCase in the lung of wild-type mice
and animals with an exaggerated Th2 response that is
dominated by the cytokines IL4 and IL13. This induc-
tion did not occur in mice with an exaggerated Th1 re-
sponse or IL13-knockout mice (Sandler et al. 2003).
Zimmermann et al. (2004) reported highly induced
AMCase mRNA levels in mouse models of experimental





 antigen. This induction was mediated by
the STAT6 signaling pathway, again suggesting a role
for IL4 or IL13 (Zimmermann et al. 2004). Very re-
cently it was shown for an aeroallergen asthma mouse
model that AMCase is induced in the lung via a Th2-
specific, IL13-mediated pathway (Zhu et al. 2004). In-
terestingly, AMCase activity appeared instrumental
for the pathogenesis of asthma. Inhibition of AMCase,
either by a specific antibody or the specific chitinase
inhibitor allosamidin, alleviated the Th2-mediated in-
flammatory damage that occurs in asthma (Zhu et al.
2004). It has been suggested that inhibition of chitin-
ase activity may render an attractive new therapy for
asthma (Couzin 2004; Zhu et al. 2004).
So far, all attention in studies with mouse models
has been focused on AMCase, whereas chitotriosidase,
the dominant chitinase in man, has received little at-
tention. We investigated the expression of chitotriosi-
dase and AMCase in mice in more detail. We show here
that remarkable differences between man and mouse
exist regarding cell type and tissue-specific expression
of chitinases. Comparison of promoter sequences of
the human and murine chitinase genes helps to explain
the species-specific tissue expression of chitinases. The
implications for extrapolating observations on chitin-







Chitinase enzyme activity was determined with the fluo-






















totriose; Sigma). Assay mixtures contained 0.027 mM sub-
strate and 1 mg/ml of bovine serum albumin in McIlvaine
buffer (100 mM citric acid, 200 mM sodium phosphate) at
the indicated pH. The standard enzyme activity assay for hu-
man chitotriosidase with 4MU-chitotriose substrate was
performed at pH 5.2, as previously described (Hollak et al.
1994). The standard AMCase enzyme activity assays with
4MU-chitobiose substrate were performed at pH 4.5.
 
RNA Isolation, Northern Blot, and RNA Master
Blot Analysis
 
Total spleen RNA was isolated using the RNAzol B (Bio-
solve; Barneveld, The Netherlands) RNA isolation kit ac-





g samples of total RNA were run in 10 mM
Hepes (pH 7.5), 6% formaldehyde–agarose gels, transferred
to Hybond N nylon membranes (Amersham; Buckingham-
shire, UK) by the capillary method, and immobilized by UV
cross-linking. Full-length mouse chitotriosidase cDNA was
used as probe. Human RNA Master Blots (Clontech; Palo
Alto, CA) were used to examine the tissue distribution of the
human chitotriosidase transcript according to the instructions
of the manufacturer, using the full-length human chitotriosi-





using the random priming method. Hybridization conditions




The native isoelectric point of chitinases was determined by
flatbed isoelectric focusing in granulated Ultrodex gels (Phar-
macia; Uppsala, Sweden) as described (Renkema et al. 1995).
 
cDNA Cloning of the Mouse Chitotriosidase
 
Reverse transcription–polymerase chain reaction (RT-PCR)
fragments were generated from mouse pooled tissue total
RNA using degenerate oligonucleotides, as described (Boot
et al. 1995). Obtained fragments were cloned in pGEM-T





























the GenBank mouse expressed sequence tag (EST) database
using the basic local alignment search tool (BLAST) at the
National Center for Biotechnology Information showed that
several EST clones matched the mouse chitotriosidase cDNA
sequence. Full-length mouse chitotriosidase cDNA was gen-
erated using specific primers based on these deposited se-
quences. The nucleotide sequence of two independent clones
from the PCR were sequenced from both strands by the pro-
cedure of Sanger using fluorescent nucleotides on an Applied
Biosystems (ABI; Foster City, CA) 377A automated DNA se-
quencer following ABI protocols.
 
Transient Expression in COS-1 Cells
 
Transient expression of the various cDNAs in COS-1 cells
was performed to generate recombinant enzyme exactly as




More detailed practical protocols for fixation, paraffin em-
bedding, mounting, and sectioning have been described (Moor-
man et al. 2000). In short, tissues removed from a FVB
mouse were fixed for 4 hr to overnight in freshly prepared
4% formaldehyde in PBS by rocking at 4C. The tissues were
then dehydrated in a graded ethanol series, paraffin embed-
ded, cut into sections, and carefully mounted on aminoalkyl-
silane-coated slides to prevent loss of the tissue sections dur-
ing the extensive treatments of the in situ hybridization
(ISH) procedure.
 
RNA Probes and Probe Specification
 
Digoxigenin-labeled probes were made according to the
manufacturer’s specifications (Roche; Mannheim, Germany).
RNA probes complementary to the full-length mouse mRNAs
encoding chitotriosidase, AMCase, GOB-5 or calcium-acti-
vated chloride channel 3, glutamine synthase, and lysozyme
P were used. Due to the high identity, the lysozyme probe





Non-radioactive ISH was performed as described (Moorman
et al. 2001). In short, after removal of paraffin, sections
were pretreated by proteolytic digestion for 5–15 min at




g/ml proteinase K dissolved in PBS, followed
by a 5-min rinse in 0.2% glycine/PBS, and two rinses of 5
min in PBS. Sections were then re-fixed for 20 min in 4%
formaldehyde/0.2% glutaraldehyde dissolved in PBS to en-
sure firm attachment of the sections to the microscope slides
and washed twice in PBS for 5 min. Sections were prehybrid-
ized in hybridization mix without probe for 1 hr at 70C and
then hybridized overnight at 70C. The hybridization mix-




 SSC, 1% block
solution (Roche), 5 mM EDTA, 0.1% Tween-20, 0.1% Chaps
(Sigma), 0.1 mg/ml heparin (Becton-Dickinson; Mountain














tion mix was applied to the sections, and no coverslips were










 SSC, pH 4.5, followed by three 5-min washes in
PBST. Probe bound to the section was immunologically de-
tected using sheep anti-digoxigenin Fab fragment covalently
coupled to alkaline phosphatase and NBT/BCIP as chro-
mogenic substrate, essentially according to the manufacturer’s
protocol (Roche). Sections were washed with double-distilled
water, dehydrated in a graded ethanol series and xylene, and




The mouse and human ortholog of the AMCase have
been identified recently (Boot et al. 2001). The human
AMCase gene is located on chromosome 1p13, whereas
the locus of the human chitotriosidase gene is found on
chromosome 1q32 (Boot et al. 1998). The mouse AMC-
ase gene is located on chromosome 3F3, a region that
is syntenic with human 1p13. Recently, we and others
have cloned the mouse ortholog of human chitotriosi-
dase (GenBank Accession numbers: AY536287.1 and
AY458654.1, respectively).
Alignment of mouse and human chitotriosidase amino
acid sequences revealed that there is an identity of 75%
and a similarity of 78%. To group all the known mouse
and human chitinase protein family members and to de-
termine whether this cloned sequence is the true ortholog
of human chitotriosidase, multiple sequence alignments
of their cDNAs, coding for the catalytic 39-kDa domain
only, were made using the Clustal X program (Thompson
et al. 1997). The sequences used for this alignment are
human chitotriosidase (GenBank Accession Number:
U29615), human-HC gp39 (GenBank Accession Num-
ber: M80927), human-AMCase (GenBank Accession
Number: AF290004), human-oviductin (GenBank Ac-
cession Number: U09550), human-YKL39 (GenBank Ac-
cession Number: U49835), mouse-BRP39 (GenBank
Accession Number: X93035), mouse-YM1 (GenBank
Accession Number: M94584), mouse-AMCase (Gen-
Bank Accession Number: AF290003), and mouse-ovi-
ductin (GenBank Accession Number: D32137). Group-
ing of these members is calculated by the method of
Neighbor Joining by Saitou and Nei (Saitou and Nei
1987). This analysis showed that the cloned mouse se-
quence is grouped together with human chitotriosi-
dase. It suggests that the mouse sequence is more ho-
mologous to human chitotriosidase than to any other
member of the chitinase protein family, which is indic-
ative of being orthologs of each other.
Using the Mouse Genome Server from the Mouse
Genome Sequencing Consortium (at http://www.
ensembl.org/Mus_musculus), we identified genomic se-
quences that contained the chitotriosidase gene, en-
abling the determination of intron–exon boundaries.
The boundaries are all conserved between human and
mouse chitotriosidase genes (data not shown). More-
over, it was found that the mouse chitotriosidase gene
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ary with F. This region is syntenic with human chro-
mosome 1q32. On human 1q32, only two genes of
members of the chitinase protein family are located,
namely, chitotriosidase (CHIT1) and HC gp39 (CHI3L1)
(Jin et al. 1998). On mouse chromosome 1 band E4
the mouse BRP39 (Chi3l1), the mouse ortholog of HC
gp39, was already identified (Jin et al. 1998). The data
present on the Mouse Genome Server show that, in
addition to the BRP39 gene, the mouse chitotriosidase
gene is also found at this locus (see Figure 1 for over-
view). In addition to the syntenic chromosomal loca-
tions, the homology in intronic sequences of the
mouse and human chitotriosidase genes indicate that
they are orthologs.
Comparison of the properties of human and mouse
chitotriosidases revealed that both enzymes show a pH
optimum that is relatively broad and peaks around pH 6
(Figure 2A). Like human chitotriosidase, the mouse
enzyme is not acid stable in sharp contrast to the mouse
AMCase, which is extremely acid stable (Figure 2B).
Northern blot analysis of different mouse tissues
with the mouse chitotriosidase cDNA probe revealed
highest expression in tongue and slightly less in the
stomach. In other tissues, expression was not detect-
able (Figure 3A). The expression pattern of human
chitotriosidase is remarkably different. Human chito-
triosidase is expressed at relatively high levels in lymph
node, bone marrow, and lung as determined with
commercial tissue dot blot (Figure 3B). No expression
of chitotriosidase was detectable in the human stom-
ach. Human AMCase was found to be relatively
highly expressed in the stomach and to a lesser extent
in the human lung using the same commercial RNA
Master Blot (Boot et al. 2001). Moreover, previously
it was also observed by Northern blot analysis that
AMCase is expressed predominantly in the stomach,
salivary glands, and lungs of mice (Boot et al. 2001).
Non-radioactive ISH was used to examine more
Figure 1 Schematic overview of the
synteny of mouse locus 1E4 with hu-
man 1q32. On the left-hand side,
mouse chromosome 1 with a part of
locus 1E4 is indicated. On the right-
hand side, the human syntenic region
1q32 is shown. The orientation and
position of a few genes in the direct
neighborhood of the mouse and hu-
man chitotriosidase gene are de-
picted. The genes of members of the
chitinase protein family are depicted
in dark gray arrows, whereas the
other genes are indicated with light
gray arrows. The genes are BTG2, Btg2:
B-cell translocation gene 2; CHIT1,
Chit1: chitotriosidase; CHI3L1, Chi3l1:
cartilage glycoprotein 39; MYBPH,
Mybph: myosin-binding protein H;
ADORA1, Adora1: adenosine A1 re-
ceptor; LOC388729: gene coding for
the human hypothetical protein with
GenBank Accession Number: XP373882.
Figure 2 (A) pH activity profile of the different recombinant chito-
triosidases. The pH optima were determined by monitoring enzyme
activity at the indicated pH in McIlvaine buffer. Purified human re-
combinant chitotriosidase (closed circle), purified recombinant
mouse chitotriosidase (closed triangle). (B) Acid stability. Purified
recombinant mouse chitotriosidase, human chitotriosidase, and
mouse AMCase were preincubated for 30 min at the indicated pH
in McIlvaine buffer prior to enzyme activity measurement at the as-
say pH (see Materials and Methods). Activity prior to incubation at

























Tissue-specific Expression of Mouse Chitinases
 
1287
Figure 3 Tissue distribution of mouse chitotriosidase mRNA. (A) Northern blot of RNA isolated from the indicated mouse tissues. Fifteen
g total RNA was separated on an agarose gel as described in Materials and Methods. The full-length mouse chitotriosidase cDNA was used
as probe. Lower part of the figure shows the ethidium bromide-stained gel as a control for RNA loading. The position of the 18S rRNA band
is indicated. Lane 1, bone marrow; Lane 2, lymph node; Lane 3, tongue; Lane 4, brain; Lane 5, stomach; Lane 6, lung; Lane 7, kidney; Lane 8,
liver; Lane 9, colon; Lane 10, small intestine. (B) The relative expression levels of human chitotriosidase in various tissues as determined by
dot blot analysis using a RNA Master Blot (Clontech) as described under Materials and Methods. The tissue with the highest levels of chito-
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closely the cellular sources of mouse chitotriosidase and
mouse AMCase. As references, the expression of other
genes was visualized. The genes used as reference are
lysozyme P because of the analogy with chitinases,
GOB-5, a calcium-activated chloride channel and gob-
let cell marker, and glutamine synthase as a positive
control for expression in the stomach and liver.
Using ISH, no mRNA for chitotriosidase and AMC-
ase was detectable in brain, colon, pancreas, liver,
heart, kidney, skin, and spleen (data not shown) in
agreement with the results obtained with the Northern
blot analysis. The expression of chitinases in the gas-
trointestinal tract of mice is complex. Starting in the
mouth, profound expression of both chitinases is ob-
served. Chitotriosidase expression was mainly detected
in the mucosal surface of the tongue in the stratified
squamous epithelium of the papilla (Figures 4A–4E).
Whereas AMCase is mainly found in the specialized
minor lingual salivary glands of the serous type, the
so-called glands of von Ebner (Figures 4F and 4G), in
agreement with the results described (Suzuki et al.
2002; Goto et al. 2003), in the major salivary glands
intense expression of AMCase was observed in the pa-
rotid gland (Figures 5A–5C), and no expression of chi-
totriosidase was noted (data not shown).
Moreover, unlike the situation in humans, both chitin-
ases are highly expressed in the mouse stomach (Fig-
ures 5D–5H). However, chitotriosidase expression is
restricted to the non-glandular fore-stomach, whereas
mRNA is found in the stratified squamous epithelial
layer. Glutamine synthase mRNA is also found in this
region of the stomach, in a cell layer just beneath that
of the chitotriosidase-expressing cells (Figures 5G and
5H). In agreement with the results of Suzuki et al.
(2002) and Goto et al. (2003), we found that AMCase
is expressed in the glandular portion of the stomach,
at the bottom of the gastric glands in chief cells (Fig-
ures 5D and 5E). The pyloric glands in the antrum of
the stomach show no expression of the chitinases. Fur-
ther down the gastrointestinal tract, in the duodenum
but also in other parts of the small intestine, chitotri-
osidase is expressed by Paneth cells in the crypts of
Lieberkühn (Figures 5I–5K). A similar expression is
observed for lysozyme. We were unable to detect AMC-
ase in the intestine.
The expression of chitinases in the lung is of partic-
ular interest. In normal human lung, chitotriosidase is
prominently expressed by alveolar macrophages. In
sharp contrast, we were unable to detect significant
amounts of chitotriosidase mRNA in murine lung. On
Figure 4 Non-radioactive in situ hy-
bridization (ISH) on the tongue of
normal mice. Non-radioactive ISH was
performed on sections of the mouse
tongue. Probe bound to the sections
were immunologically detected us-
ing sheep anti-digoxigenin Fab frag-
ment covalently coupled to alkaline
phosphatase and NBT/BCIP as chro-
mogenic substrate. The sections are
not counterstained, and blue/black
precipitates indicate specific mRNA
expression. (A) Overview of the whole
tongue. Upper serial section is stained
with hematoxylin–azophlochsin, mid-
dle section shows expression of chi-
totriosidase, and lower section shows
expression of AMCase. (B) Close-up of
hematoxylin–azophlochsin-stained up-
per surface of the tongue with the fil-
iform papillae (see upper rectangle,
overview in A). Original magnifica-
tion 400. (C) Close-up of the upper
surface of the tongue showing ex-
pression of chitotriosidase in the strat-
ified squamous epithelium (see upper
rectangle, overview in A). Original
magnification 400. (D) Close-up of
the hematoxylin–azophlochsin-stained
lower surface of the tongue (see
lower rectangle, overview in A). Orig-
inal magnification 200. (E) Close-up
of the same region as in (D) showing
expression of chitotriosidase in the stratified squamous epithelium. Original magnification 200. (F) Close-up of the minor lingual salivary
glands (see right-hand rectangle, overview in A). The arrow indicates the serous type glands (von Ebner’s glands), whereas the arrowhead
indicates the mucous type of the lingual salivary glands. Original magnification 200. (G) Close-up of the same region as in (F) showing ex-





























the other hand, AMCase mRNA is expressed by alve-
olar macrophages in the mouse (Figure 6).
To rule out mice strain-related effects as the basis
for the observed differences in chitotriosidase expres-
sion, the activity of chitinases was measured in various
relevant tissues (lung, liver, spleen, stomach, several
parts of the intestine, kidney, salivary glands, tongue,
and blood) from male FVB and C57BL/6 mice at dif-
ferent pHs. The relative distribution of activities was
identical for both mice strains at all pHs measured,
clearly indicating that the pattern of chitinase expres-
sion in these different mouse strains is preserved. How-





higher in FVB tissues compared with the correspond-
ing tissues from C57BL/6 mice.
The remarkable difference in expression of mouse
Figure 5 Non-radioactive ISH on the
gastrointestinal tract of normal mice.
Non-radioactive ISH was performed
on sections containing different tis-
sues of the gastrointestinal tract. Probe
bound to the sections were immuno-
logically detected using sheep anti-
digoxigenin Fab fragment covalently
coupled to alkaline phosphatase and
NBT/BCIP as chromogenic substrate.
The sections are not counterstained,
and blue/black precipitates indicate
specific mRNA expression. (A) Over-
view of the major salivary glands with
specific AMCase expression in the pa-
rotid gland (arrow). (B) Serial section
of the salivary glands stained with he-
matoxylin–azophlochsin. (C) Close-up
of a part of the parotid gland (arrow
from B). Original magnification 100
stained with hematoxylin–azophloch-
sin. (D) Overview of the whole stom-
ach with specific expression of AMC-
ase in the glandular portion of the
stomach (arrows). (E) Close-up of the
glandular portion of the stomach with
strong expression of AMCase at the
bottom of the gastric glands in chief
cells. Original magnification 200. (F)
Overview of the whole stomach with
specific expression of chitotriosidase in
the non-glandular fore-stomach (ar-
row). (G) Close-up of the fore-stomach
with strong expression of chitotriosi-
dase in the stratified squamous epi-
thelial layer. Original magnification
200. (H) Same region and magnifica-
tion with expression of glutamine syn-
thase in a cell layer just beneath in
the stratified squamous ephithelial
layer. Original magnification 200. (I)
Expression of lysozyme P in by Paneth
cells in the crypts of Lieberkühn in the
ileum (arrow). Original magnifica-
tion 50. (J) Serial section of the il-
eum with specific expression of chi-
totriosidase in the same Paneth cells
(arrow). (K) Close-up of the intestinal
wall showing expression of chitotri-
osidase in Paneth cells (arrow). Origi-
nal magnification 200. (L) Close-up
of an intestinal villus with specific ex-
pression of GOB-5 (arrow), which spe-
cifically stains goblet cells in the intes-
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and human chitotriosidase was further investigated by
analysis of the promoter regions. Mouse EST cDNA




 untranslated region indi-
cate that the mouse chitotriosidase gene has an extra
exon compared with the human gene. This first exon
is located at least 7000 bp upstream. The human chi-
totriosidase promoter is homologous to a region found
in mouse intron 1 just upstream of exon 2. In conclu-
sion, the promoter of the mouse chitotriosidase gene
differs fundamentally from the human one (Figure 7).
This likely explains the noted differences in cell type




Striking analogies exist between mammalian chitinases
and lysozymes. Both classes of enzymes are endoglu-





-linked glycans. Expression of both classes of en-
zymes is highly regulated, being restricted to certain
cell types. A dual function in defense and polysaccha-
ride processing is envisioned for lysozymes and chitin-
ases. For example, in many animals lysozyme functions
as a bacteriolytic enzyme expressed in tissue macro-
phages, but during evolution of various species it has
also been recruited for a nutritional function in the
gastrointestinal tract (Dobson et al. 1984; Jolles et al.
1984). The expression in man of chitotriosidase in
phagocytes and that of acid-stable AMCase in the gas-
trointestinal tract is reminiscent of this. Like lysozyme,
gastrointestinal chitinases might have a dual function
in defense and food processing. Research on lysozyme
has provided insight into the mechanisms that allow
the evolution of specialized lysozymes, driven by the
need of a specific organism. For example, ruminants
have duplicated the lysozyme gene to yield about ten
copies, of which several are expressed in the gastrointes-
tinal tract. Some of these enzymes have evolved into
Figure 6 Non-radioactive ISH on
mouse lung. Non-radioactive ISH was
performed as described in Materials
and Methods. Probe bound to the
sections were immunologically de-
tected using sheep anti-digoxigenin
Fab fragment covalently coupled to
alkaline phosphatase and NBT/BCIP as
chromogenic substrate. The sections
are not counterstained, and blue pre-
cipitates indicate specific mRNA ex-
pression. In the mouse lung, strong
mRNA expression could be detected
for lysozyme M (A,B). Strong expres-
sion in fewer cells could be detected
for AMCase in the mouse lung (C,D).
Original magnification (A,C) 200;
(B,D) 400. The probe that was used
to detect lysozyme M is that of lyso-
zyme P, because the mRNA sequence
of both lysozyme genes is almost
identical, and both mRNA are de-
tected with the used probe.
Figure 7 Schematic overview of mouse
and human chitotriosidase gene. Ho-
mology between mouse and human
chitotriosidase exons is indicated with
dotted lines. Promoters are indicated
with the black flags. The shaded flag
indicates the region in mouse intron 1






























extremely acid-stable proteins with an acidic pH opti-
mum dependent on the site of expression (Irwin 1996;
Prager 1996). A very similar process seems to have
taken place in the mammalian chitinase family. Dupli-
cations have occurred, ultimately leading to special-
ized chitinases. In the gastrointestinal tract of the mouse,
chitotriosidase is produced at sites of near neutral pH
such as the mouth, the non-glandular portion of the
stomach, and the small intestine. The expression from
the oral cavity to the fore-stomach seems to be re-
stricted to the stratified squamous epithelial cell layer.
Chitotriosidase and AMCase activity can be found in
the lumen of the gastrointestinal tract, suggesting that
these cells secrete the enzyme to the luminal site. How-
ever, besides AMCase, considerable chitotriosidase ac-
tivity can also be found in the circulation. At this time
we do not know the exact cellular source of chitotri-
osidase in the blood. We therefore cannot exclude that
a portion of the chitotriosidase produced by the strati-
fied epithelial layer is secreted to the blood. Alterna-
tively, it is possible that another, so far unidentified,
cell type is responsible for the chitotriosidase in the
circulation.
The acid-stable AMCase is produced predominantly
in the glandular portion of the stomach, at the bottom
of the gastric glands in chief cells, close to the acid-
producing parietal cells, consistent with its features.
Stomach lysozymes from ruminants have adapted to
function optimally in the hostile acid environment by
subtle changes in amino acid composition. The same is
also the case for the mouse AMCase that has also
adapted to function in the stomach. Analysis of the
three-dimensional structure of chitotriosidase and AMC-
ase should reveal the key amino acid substitutions re-
quired for the adaptation. The available information
on the structure of chitotriosidase should assist further
investigations on this matter (Fusetti et al. 2002).
The human AMCase is less well equipped to func-
tion in a highly acidic environment compared with the
mouse enzyme. Differences in physiology or diet may
have contributed to this. Live insects are an important
component in the diet of wild mice (Landry 1970).
Intriguingly, in the cow AMCase is produced and
secreted by the liver and is present in large amounts in
serum (Suzuki et al. 2001). The function of the enzyme
is unclear. It seems likely that expression is driven by
yet another type of promoter, adding to the rapidly
growing complexity of the mammalian chitinase pro-
tein family.
Overexpression of chitinases occurs in a number of
pathologies in mouse and man. Chitotriosidase is the
dominant chitinase in man that is highly expressed in
specific cell types including tissue macrophages. In var-
ious disorders in which activated macrophages are im-
plicated, elevated plasma chitotriosidase levels occur,
e.g., lysosomal lipid storage disorders, sarcoidosis, vis-
ceral Leishmaniasis, extended atherosclerosis such as
Tangier disease, and thalassemia (Hollak et al. 1994;
Barone et al. 1999; Boot et al. 1999; Grosso et al.
2004). In sharp contrast, in mice, expression of chito-
triosidase is confined to the gastrointestinal tract and
AMCase seems to be the sole endogenous chitinase in
tissues such as lung. These species differences seem to
be due to distinct promoters of the chitotriosidase genes
in mouse and man. The mouse chitotriosidase tran-
scription start site is located far upstream compared
with the human situation because the mouse gene con-




 end. Homology is noted
between the human promoter and a region in intron 1
of the mouse gene, just upstream of the second exon.
Whether this region can indeed act as an alternative
promoter for the mouse chitotriosidase gene is at present
not known and a topic of further investigation.
The promoter regions of the mouse and human
AMCase genes are relatively comparable.
In contrast to Suzuki and coworkers (2002), we were
able to detect AMCase mRNA in murine lung with
ISH, confirming our Northern blot analysis (Boot et
al. 2001). This discrepancy might be due to differences
in mice strains or to the sensitivity of the ISH meth-
ods. The expression of AMCase mRNA is found to be
induced in the lung of mice under various pathological
conditions, most strikingly in Th2-driven asthma mod-
els (Sandler et al. 2003; Xu et al. 2003; Zhu et al.
2004; Zimmermann et al. 2004). Prominently increased
expression of AMCase has also been observed in lung
biopsies from asthmatic patients (Zhu et al. 2004).
A surprising role has recently been ascribed to chitin-
ases in the pathogenesis of asthma. It was found that
inhibition of chitinase activity in lungs of asthmatic
mice alleviates the inflammatory pathology (Zhu et al.
2004). This opens a potential new avenue for thera-
peutic intervention, i.e., the use of specific chitinase in-
hibitors such as allosamidin (Zhu et al. 2004). How-
ever, extrapolation of the findings with mice to man is
complicated by the fact that it is presently unclear
whether in addition to AMCase, chitotriosidase is also
overexpressed in lung of asthmatic patients. It has
been shown that in sarcoidosis, a systemic granuloma-
tous disease, chitotriosidase is elevated in plasma and
bronchoalveolar lavage (Hollak et al. 1994; Grosso et
al. 2004). It is therefore unclear whether inhibition of
both AMCase and chitotriosidase would be required
for intervention in the inflammatory process in lungs
of asthmatic patients. It may also be possible that se-
lective inhibition of AMCase is more desirable. In this
regard, it will be of interest to study whether the rela-
tively common chitotriosidase deficiency influences the
clinical course of asthma.
In conclusion, the remarkable differences in cell
type and tissue-specific expression of chitotriosidase in
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ferent promoter regions, gene duplications, and differ-
ent environmental pressures during the evolution of these
different species. Further research is required regard-
ing the physiological functions of the chitinase and
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